Hercules Capital Receives SBA ‘Green Light’ Letter to Submit Fourth SBIC License Application

The U.S. Small Business Administration issued a “green light” letter inviting Hercules Capital to submit an application to obtain a license to form and operate a fourth small business investment company (SBIC) subsidiary, following the company’s recent presentation to the SBA committee.

November 10, 2023 Hercules Capital | Scott Bluestein Ian Koplin

Hercules Capital Provides $50MM Loan Facility to Senseonics Holdings

Senseonics Holdings, a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring systems for people with diabetes, entered into a $50 million loan facility with Hercules Capital.

September 12, 2023 Bryan Jadot | Hercules Capital | Rick Sullivan | Senseonics Holdings Ian Koplin

Hercules Capital Provides $115MM Loan Facility to X4 Pharmaceuticals

X4 Pharmaceuticals, a provider and developer of novel small-molecule therapeutics to benefit people with rare diseases of the immune system, closed a $115 million loan facility with Hercules Capital. The company also announced that it drew down $22.5 million upon the transaction’s closing.

August 4, 2023 Adam Mostafa | Bryan Jadot | Hercules Capital | X4 Pharmaceuticals Ian Koplin

Hercules Capital Provides $50MM Term Loan Facility to COMPASS Pathways

COMPASS Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, entered into a term loan agreement with Hercules Capital for up to $50 million.

July 6, 2023 Bryan Jadot | COMPASS Pathways | Goodwin Procter | Hercules Capital | Kabir Nath | Morrison Foerster¸ Armentum Partners Ian Koplin

Hercules Capital Establishes New Private Credit Lending Program for Venture Companies

Hercules Adviser, a wholly-owned subsidiary of Hercules Capital, established a new institutional private credit lending program to support venture and growth stage companies being impacted by recent market events across the venture and growth stage lending ecosystem.

March 27, 2023 Hercules Advisor | Hercules Capital | Scott Bluestein Phil Neuffer

SMBC Increases Hercules Capital’s Letter of Credit Facility to $175MM

Hercules Capital increased its committed letter of credit facility with Sumitomo Mitsui Banking Corporation by $75 million for a total of $175 million in credit capacity, subject to borrowing base, leverage and other restrictions.

March 23, 2023 Hercules Capital | Seth Meyer | Sumitomo Mitsui Banking Corporation Phil Neuffer

Hercules Capital Provides $50MM in Debt Financing to AmplifyBio

AmplifyBio augmented its balance sheet with non-dilutive debt financing, whereby it may borrow a principal amount of up to $50 million from Hercules Capital.

January 13, 2023 AmplifyBio | Bryan Jadot | Hercules Capital | J. Kelly Ganjei Ian Koplin

Silicon Valley Bank and Hercules Capital Provide $300MM Credit Facility to Oak Street Health

Silicon Valley Bank and Hercules Capital provided a $300 million credit facility to Oak Street Health, a network of value-based primary care centers for adults on Medicare. The financing is intended to provide Oak Street Health with operational and strategic capital for the next several years.

November 17, 2022 Hercules Capital | Michael Dutra | Oak Street Health | Silicon Valley Bank | Tim Cook | Tom Hertzberg Ian Koplin

Hercules Capital Provides $125MM Debt Facility to Tricida

Tricida entered into a debt facility with Hercules Capital. The total amount of the debt facility is $125 million of which $100 million will be available for drawdown at Tricida’s option subject to the achievement of certain milestones.

October 20, 2022 Geoff Parker | Hercules Capital | Scott Bluestein | Tricida Ian Koplin

Hercules Capital Provides $200MM Term Loan Facility to Replimune Group

Replimune Group, a clinical stage biotechnology company pioneering the development of a novel class of tumor-directed oncolytic immunotherapies, obtained a $200 million non-dilutive term loan facility from Hercules Capital.

October 10, 2022 Armentum Partners | Bryan Jadot | Hercules Capital | Jean Franchi | Replimune Group Ian Koplin